Zembrace Symtouch Solution
NDC Package 70792-809-89
Package Information
Zembrace Symtouch (sumatriptan succinate) solution is sumatriptan is used to treat migraines and cluster headaches. This formulation utilizes a solution delivery system. Marketed by Tonix Medicines, Inc., this product is identified by NDC 70792-809 and is authorized under FDA application NDA208223.
Identification & Billing
- RxCUI: 1738576 - SUMAtriptan 3 MG in 0.5 ML Auto-Injector
- RxCUI: 1738576 - 0.5 ML sumatriptan 6 MG/ML Auto-Injector
- RxCUI: 1738576 - sumatriptan (as succinate) 3 MG per 0.5 ML Auto-Injector
- RxCUI: 1738576 - sumatriptan 3 MG per 0.5 ML Auto-Injector
- RxCUI: 1738581 - Zembrace 3 MG in 0.5 ML Auto-Injector
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70792 - Tonix Medicines, Inc.
- 70792-809 - Zembrace Symtouch
- 70792-809-89 - 1 BLISTER PACK in 1 CARTON / 1 SYRINGE in 1 BLISTER PACK / .5 mL in 1 SYRINGE
- 70792-809 - Zembrace Symtouch
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (70792-809). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70792-809-89 identifies a specific commercial package of 1 blister pack in 1 carton / 1 syringe in 1 blister pack / .5 ml in 1 syringe of Zembrace Symtouch, a human prescription drug labeled by Tonix Medicines, Inc.. This solution is formulated for subcutaneous use and contains sumatriptan succinate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Tonix Medicines, Inc. on July 01, 2023. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Sumatriptan is used to treat migraines and cluster headaches. It helps to relieve pain and other symptoms of migraines/headaches including sensitivity to light or sound, nausea, and vomiting. Prompt treatment allows you to get back to your normal routine and may decrease your need for other pain medications. It does not prevent future migraines/headaches or reduce how often you may get a headache. Sumatriptan belongs to a group of drugs called triptans. It affects a certain natural chemical (serotonin) that constricts blood vessels in the brain. It may also block other pain pathways in the brain.
How is this Tonix Medicines, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70792080989. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.